COCO

Vita Coco Company, Inc.

Nasdaq · Beverages · Inc. DE · CIK 0001482981
$78.69 +1.04% $4.4B
Insider Selling Cluster (4 insiders)High Impact Filing (8/10)5 New Institutional Positions
Vol
Market Cap$4.4B
Cap SizeMid Cap
Inst. Holders9 funds
Inst. Value$537.0M
Inst. Activity5 buys / 0 sells
Insider Activity0B / 20S
Insider Net $-$23.5M
Reddit Sentiment50° Neutral
SEC Reports20
Press Releases1
Exchange Nasdaq·Sector Beverages·Inc. DE·CIK 0001482981·Prev Close $77.88

Recent Activity

May 14, 2026 short_volume
Short Volume: COCO — 56.6% short (0.3M / 0.6M)
Short: 331,943 | Exempt: 125 | TRF Vol: 586,818 | Short Ratio: 56.6% | Off-exchange volume (dark poo
May 12, 2026 Insider
Burth Jonathan sold 30,000 shares
Chief Operating Officer @ $10.18 ($305.3K)
May 12, 2026 Insider
Burth Jonathan sold 30,000 shares
Chief Operating Officer @ $75.00 ($2.3M)
May 12, 2026 Insider
Burth Jonathan sold 30,000 shares
Chief Operating Officer @ $0.00 ($0.00)
May 11, 2026 SEC
Two C-suite insiders at Vita Coco sold a combined $2.0M in open-market shares on May 8, 2026, following the company's bl
CLUSTER — Impact 4/10
May 5, 2026 Press
Vita Coco announced a partnership with INTENNSE tennis league as the exclusive electrolyte beverage partner for the 2026
Impact 2/10
May 4, 2026 SEC
Four top executives (CEO, COO, CCO, Executive Chairman) sold $6.1M in open-market shares within days of Vita Coco's blow
CLUSTER — Impact 5/10
May 1, 2026 SEC
Three top insiders (CEO, COO, Executive Chairman) sold a combined $5.97M in open-market sales within two days of Vita Co
CLUSTER — Impact 5/10

Price Targets

Historical data — last covering-analyst action Jul 2024. No current recommendation available.
$73.67 (Jul 2024)
Current $78.69 Low $65.00 Median $72.00 High $85.00 9 analysts
$65.00 $85.00

Analyst Ratings

Historical distribution76% buy · 17 analysts · last covering-analyst action Jul 2024
5Strong Buy
8Buy
4Hold
0Sell
0Strong Sell
Historical Analyst Actions
DateFirmActionRating
Jul 12, 2024 Piper Sandler DOWNGRADE Overweight → Neutral
Jul 10, 2024 B of A Securities MAINTAIN Neutral → Neutral
Jul 10, 2024 Wells Fargo MAINTAIN Overweight → Overweight
May 23, 2024 Stephens & Co. REITERATE Overweight → Overweight
Feb 29, 2024 Piper Sandler MAINTAIN Overweight → Overweight

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Current Q $0.54 ▲ +8.1% $0.48 — $0.60 29% YoY 3
Next Q $0.50 ▼ -2.6% $0.47 — $0.51 23% YoY 3
Current FY $1.78 ▲ +10.1% $1.69 — $1.86 34% YoY 3
Next FY $2.05 ▲ +7.0% $1.94 — $2.20 15% YoY 3

Top Institutional Holders

FundValueMove
FMR LLC$273.1MADD
VANGUARD GROUP INC$167.0M
MORGAN STANLEY$31.0MADD
TWO SIGMA INVESTMENTS, LP$23.1MADD
CHARLES SCHWAB INVESTMENT MANAGEMENT$20.0MNEW

Recent Insider Trades

DateInsiderTypeValue
May 12, 2026Burth JonathanM$305.3K
May 12, 2026Burth JonathanSELL$2.3M
May 12, 2026Burth JonathanM$0.00
May 8, 2026van EsSELL$599.3K
May 8, 2026Burth JonathanM$203.6K

Reddit Sentiment

50°
Neutral
Bearish Neutral Bullish
3 mentions 0 bullish 0 bearish
9 institutional holders with $537.0M total value (10,130,518 shares) as of 2025-Q4. Top holders: FMR, VANGUARD, MORGAN. Net buying activity: 5 institutions added/increased vs 0 reduced.

Top Institutional Holders — 2025-Q4

#FundSharesValue% of TrackedLast Move
1FMR LLC5,152,158$273.1M50.9%ADD +42.4%
2VANGUARD GROUP INC3,149,584$167.0M31.1%
3MORGAN STANLEY585,439$31.0M5.8%ADD +31.6%
4TWO SIGMA INVESTMENTS, LP435,925$23.1M4.3%ADD +70.7%
5CHARLES SCHWAB INVESTMENT MANAGEMENT INC376,470$20.0M3.7%NEW
6BANK OF AMERICA CORP /DE/272,760$14.5M2.7%ADD +55.6%
7WELLS FARGO & COMPANY/MN106,677$5.7M1.1%ADD +65.2%
8RENAISSANCE TECHNOLOGIES LLC29,800$1.6M0.3%NEW
9NORGES BANK21,705$1.2M0.2%NEW

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
FMR LLCADD3,617,3125,152,158+42.4%$273.1M2025-Q4
BANK OF AMERICA CORP /DE/ADD175,333272,760+55.6%$14.5M2025-Q4
WELLS FARGO & COMPANY/MNADD64,590106,677+65.2%$5.7M2025-Q4
RENAISSANCE TECHNOLOGIES LLCNEW29,800$1.6M2025-Q4
NORGES BANKNEW21,705$1.2M2025-Q4
MORGAN STANLEYADD427,141562,175+31.6%$23.9M2025-Q3
UBS Group AGDOUBLED216,757483,902+123.2%$20.6M2025-Q3
TWO SIGMA INVESTMENTS, LPADD252,173430,385+70.7%$18.3M2025-Q3
BANK OF AMERICA CORP /DE/ADD90,869175,333+93.0%$7.4M2025-Q3
WELLS FARGO & COMPANY/MNTRIM164,81564,590-60.8%$2.7M2025-Q3
RENAISSANCE TECHNOLOGIES LLCEXIT7,6000-100.0%$0.002025-Q3
FMR LLCDOUBLED1,264,0023,324,879+163.0%$120.0M2025-Q2
MORGAN STANLEYADD279,846427,141+52.6%$15.4M2025-Q2
UBS Group AGTRIM408,338216,757-46.9%$7.8M2025-Q2
BANK OF AMERICA CORP /DE/NEAR_EXIT748,76290,869-87.9%$3.3M2025-Q2
RENAISSANCE TECHNOLOGIES LLCNEAR_EXIT46,8007,600-83.8%$274.4K2025-Q2
UBS Group AGTRIM654,818408,338-37.6%$12.5M2025-Q1
CITADEL ADVISORS LLCADD215,937270,559+25.3%$8.3M2025-Q1
TWO SIGMA INVESTMENTS, LPTRIM387,045225,927-41.6%$6.9M2025-Q1
WELLS FARGO & COMPANY/MNDOUBLED39,368151,459+284.7%$4.6M2025-Q1
RENAISSANCE TECHNOLOGIES LLCDOUBLED12,40046,800+277.4%$1.4M2025-Q1
UBS Group AGDOUBLED169,655654,818+286.0%$24.2M2024-Q4
MORGAN STANLEYADD187,163364,464+94.7%$13.5M2024-Q4
CITADEL ADVISORS LLCDOUBLED59,892215,937+260.5%$8.0M2024-Q4
RENAISSANCE TECHNOLOGIES LLCNEW12,400$457.7K2024-Q4
5 unique insiders with 20 transactions. Net insider value: -$23.5M ($0.00 bought, $23.5M sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
May 12, 2026Burth JonathanChief Operating OfficerM30,000$10.18$305.3K
May 12, 2026Burth JonathanChief Operating OfficerSELL30,000$75.00$2.3M
May 12, 2026Burth JonathanChief Operating OfficerM30,000$0.00$0.00
May 8, 2026van Es CharlesChief Commercial OfficerSELL8,561$70.00$599.3K
May 8, 2026Burth JonathanChief Operating OfficerM20,000$10.18$203.6K
May 8, 2026Burth JonathanChief Operating OfficerSELL20,000$70.00$1.4M
May 8, 2026Burth JonathanChief Operating OfficerM20,000$0.00$0.00
May 1, 2026van Es CharlesChief Commercial OfficerSELL2,000$66.87$133.7K
Apr 30, 2026Burth JonathanChief Operating OfficerM20,000$10.18$203.6K
Apr 30, 2026Burth JonathanChief Operating OfficerSELL20,000$67.50$1.4M
Apr 30, 2026Burth JonathanChief Operating OfficerM20,000$0.00$0.00
Apr 30, 2026Kirban MichaelExecutive ChairmanSELL50,000$68.00$3.4M
Apr 29, 2026Roper MartinChief Executive OfficerM20,544$0.00$0.00
Apr 29, 2026Roper MartinChief Executive OfficerSELL20,544$59.35$1.2M
Apr 29, 2026Roper MartinChief Executive OfficerM20,544$10.18$209.1K
Apr 29, 2026Burth JonathanChief Operating OfficerM20,000$10.18$203.6K
Apr 29, 2026Burth JonathanChief Operating OfficerSELL20,000$65.00$1.3M
Apr 29, 2026Burth JonathanChief Operating OfficerM20,000$0.00$0.00
Apr 28, 2026Roper MartinChief Executive OfficerSELL25,000$51.13$1.3M
Apr 28, 2026Roper MartinChief Executive OfficerM25,000$0.00$0.00
Apr 28, 2026Roper MartinChief Executive OfficerM25,000$10.18$254.5K
Apr 27, 2026Roper MartinChief Executive OfficerM25,000$10.18$254.5K
Apr 27, 2026Roper MartinChief Executive OfficerSELL25,000$50.00$1.3M
Apr 27, 2026Roper MartinChief Executive OfficerM25,000$0.00$0.00
Apr 24, 2026Roper MartinChief Executive OfficerM25,000$10.18$254.5K
Apr 24, 2026Roper MartinChief Executive OfficerSELL25,000$50.00$1.3M
Apr 24, 2026Roper MartinChief Executive OfficerM25,000$0.00$0.00
Apr 16, 2026Roper MartinChief Executive OfficerM25,000$0.00$0.00
Apr 16, 2026Roper MartinChief Executive OfficerM25,000$10.18$254.5K
Apr 16, 2026Roper MartinChief Executive OfficerSELL25,000$50.00$1.3M
Apr 15, 2026Sadowsky KennethDirectorSELL3,900$48.93$190.8K
Apr 15, 2026Roper MartinChief Executive OfficerM25,000$10.18$254.5K
Apr 15, 2026Roper MartinChief Executive OfficerSELL25,000$50.11$1.3M
Apr 15, 2026Roper MartinChief Executive OfficerM25,000$0.00$0.00
Apr 14, 2026Roper MartinChief Executive OfficerM25,000$10.18$254.5K
Apr 14, 2026Roper MartinChief Executive OfficerSELL25,000$50.00$1.3M
Apr 14, 2026Roper MartinChief Executive OfficerM25,000$0.00$0.00
Apr 13, 2026Roper MartinChief Executive OfficerM4,456$10.18$45.4K
Apr 13, 2026Roper MartinChief Executive OfficerSELL4,456$50.55$225.2K
Apr 13, 2026Roper MartinChief Executive OfficerM4,456$0.00$0.00
Apr 10, 2026Roper MartinChief Executive OfficerM25,000$10.18$254.5K
Apr 10, 2026Roper MartinChief Executive OfficerSELL25,000$50.11$1.3M
Apr 10, 2026Roper MartinChief Executive OfficerM25,000$0.00$0.00
Apr 8, 2026Roper MartinChief Executive OfficerSELL25,000$50.95$1.3M
Apr 8, 2026Roper MartinChief Executive OfficerM25,000$10.18$254.5K
Apr 8, 2026Roper MartinChief Executive OfficerM25,000$0.00$0.00
Apr 7, 2026Roper MartinChief Executive OfficerSELL25,000$50.00$1.3M
Apr 7, 2026Roper MartinChief Executive OfficerM25,000$10.18$254.5K
Apr 7, 2026Roper MartinChief Executive OfficerM25,000$0.00$0.00
Apr 1, 2026van Es CharlesChief Commercial OfficerSELL2,000$48.67$97.3K
20 SEC filing reports analyzed. Sentiment: 1 bullish, 6 bearish, 1 mixed, 12 neutral. Avg impact: 4.3/10.
NEUTRAL CLUSTER 4/10
Two C-suite insiders at Vita Coco sold a combined $2.0M in open-market shares on May 8, 2026, follow
May 11, 2026
BEARISH CLUSTER 5/10
Four top executives (CEO, COO, CCO, Executive Chairman) sold $6.1M in open-market shares within days
May 4, 2026
MIXED CLUSTER 5/10
Three top insiders (CEO, COO, Executive Chairman) sold a combined $5.97M in open-market sales within
May 1, 2026
NEUTRAL CLUSTER 3/10
CEO Roper Martin and COO Jonathan Burth collectively sold $2.52M in open-market shares following a s
May 1, 2026
BEARISH 144 5/10
Director and Officer Martin Roper filed a Form 144 on April 29, 2026, indicating intent to sell 20,5
Apr 29, 2026
BULLISH 8-K 8/10
Vita Coco reported Q1 2026 revenue of $179.8M (up 37% YoY) and GAAP diluted EPS of $0.50, significan
Apr 29, 2026
BEARISH 144 5/10
Martin Roper, a director and officer of Vita Coco, filed a Form 144 indicating intent to sell 25,000
Apr 28, 2026
NEUTRAL 144 3/10
Martin F. Roper, an officer of Vita Coco, filed a Form 144 to notify intent to sell 25,000 shares va
Apr 27, 2026
NEUTRAL 144 4/10
Martin F. Roper, an officer of Vita Coco, filed a Form 144 to sell up to 154,456 shares worth approx
Apr 24, 2026
NEUTRAL DEFA14A 3/10
Vita Coco Company is holding its 2026 Annual Meeting to elect Class II directors, ratify its auditor
Apr 22, 2026
BEARISH CLUSTER 6/10
Vita Coco CEO Roper Martin and director Kenneth Sadowsky sold a combined $1.44M in shares over the p
Apr 17, 2026
BEARISH CLUSTER 6/10
Vita Coco CEO Martin Roper and Director Kenneth Sadowsky sold shares in a coordinated cluster over s
Apr 16, 2026
NEUTRAL 144 4/10
Martin F. Roper, an officer and director of Vita Coco, filed a Form 144 to propose the sale of up to
Apr 16, 2026
BEARISH PRESS-RELEASE 6/10
The Vita Coco Company announced it will report Q1 2026 earnings on April 29, 2026, but did not relea
Apr 15, 2026
NEUTRAL 144 4/10
Martin F. Roper, an officer and director of Vita Coco Company, filed a Form 144 to report the propos
Apr 15, 2026
NEUTRAL 144 3/10
Martin Roper, an officer and director of Vita Coco, filed a Form 144 to notify intent to sell 99,456
Apr 14, 2026
NEUTRAL 144 3/10
Martin Roper, an officer and director of Vita Coco, filed a Form 144 to notify intent to sell 75,000
Apr 13, 2026
NEUTRAL 8-K 3/10
John Leahy, a board member of Vita Coco Company since 2019 and member of both the Audit and Compensa
Apr 10, 2026
NEUTRAL 144 3/10
Martin Roper, an officer and director of Vita Coco Company, filed a Form 144 to sell up to 25,000 sh
Apr 10, 2026
NEUTRAL 144 3/10
Martin Roper, an officer of Vita Coco Company, Inc., filed a Form 144 to notify intent to sell 25,00
Apr 8, 2026
Historical analyst distribution (last covering-analyst action Jul 2024): 76% buy across 17 analysts — 5 strong buy, 8 buy, 4 hold, 0 sell, 0 strong sell. No current recommendation available.

Analyst Price Targets

Historical data — last covering-analyst action Jul 2024. No current recommendation available.
$73.67 mean target (Jul 2024)
$65.00 Low $85.00 High
MetricValue
Current Price$78.69
Target Low$65.00
Target Mean$73.67
Target Median$72.00
Target High$85.00
# Analysts9
Recommendation— (no recent coverage)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-06-30
$0.54 $0.48 $0.60 28.9% +8.1% 2↑ 0↓ $0.2B 22.8% 3
Next Q
2026-09-30
$0.50 $0.47 $0.51 22.8% -2.6% 0↑ 2↓ $0.2B 9.7% 3
Current FY
2026-12-31
$1.78 $1.69 $1.86 33.9% +10.1% 2↑ 0↓ $0.7B 20.6% 3
Next FY
2027-12-31
$2.05 $1.94 $2.20 15.2% +7.0% 2↑ 0↓ $0.8B 12.0% 3

Current Quarter EPS Revision History

TimepointEPS EstimateChange
Current$0.537
7d ago$0.497+0.040
30d ago$0.497+0.040
60d ago$0.497+0.040
90d ago$0.490+0.047
11 analyst firms have rated this stock: 1 upgrades, 4 downgrades, 9 initiations.

Historical Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Jul 12, 2024 Piper Sandler DOWNGRADE Overweight Neutral
Jul 10, 2024 B of A Securities MAINTAIN Neutral Neutral
Jul 10, 2024 Wells Fargo MAINTAIN Overweight Overweight
May 23, 2024 Stephens & Co. REITERATE Overweight Overweight
Feb 29, 2024 Piper Sandler MAINTAIN Overweight Overweight
Jan 31, 2024 Goldman Sachs MAINTAIN Buy Buy
Jan 30, 2024 Goldman Sachs MAINTAIN Buy Buy
Jan 26, 2024 Piper Sandler MAINTAIN Overweight Overweight
Jan 22, 2024 William Blair DOWNGRADE Outperform Market Perform
Nov 13, 2023 Jefferies INITIATE Buy
Nov 1, 2023 Piper Sandler MAINTAIN Overweight Overweight
Oct 17, 2023 B of A Securities MAINTAIN Neutral Neutral
Sep 19, 2023 Morgan Stanley INITIATE Equal-Weight
Aug 3, 2023 Piper Sandler MAINTAIN Overweight Overweight
Aug 3, 2023 Goldman Sachs MAINTAIN Buy Buy
Aug 3, 2023 B of A Securities DOWNGRADE Buy Neutral
Jun 23, 2023 Stephens & Co. INITIATE Equal-Weight
May 4, 2023 Craig-Hallum MAINTAIN Buy
May 4, 2023 Goldman Sachs MAINTAIN Buy
May 4, 2023 Wells Fargo MAINTAIN Overweight
Apr 18, 2023 Goldman Sachs MAINTAIN Buy
Apr 17, 2023 Goldman Sachs MAINTAIN Buy
Apr 5, 2023 Craig-Hallum INITIATE Buy
Mar 9, 2023 Goldman Sachs MAINTAIN Buy
Mar 9, 2023 Wells Fargo MAINTAIN Overweight
Mar 9, 2023 Credit Suisse MAINTAIN Outperform
Jan 3, 2023 Wells Fargo MAINTAIN Overweight
Dec 15, 2022 Piper Sandler MAINTAIN Overweight
Nov 10, 2022 Wells Fargo MAINTAIN Overweight
Oct 3, 2022 Wells Fargo MAINTAIN Overweight
Aug 11, 2022 Credit Suisse MAINTAIN Outperform
Jul 8, 2022 B of A Securities UPGRADE Neutral Buy
May 16, 2022 Piper Sandler MAINTAIN Overweight
May 12, 2022 Goldman Sachs MAINTAIN Buy
May 12, 2022 Credit Suisse MAINTAIN Outperform
Apr 4, 2022 Goldman Sachs MAINTAIN Buy
Mar 14, 2022 B of A Securities DOWNGRADE Buy Neutral
Mar 11, 2022 Credit Suisse MAINTAIN Outperform
Mar 11, 2022 Wells Fargo MAINTAIN Overweight
Nov 15, 2021 Evercore ISI Group INITIATE Outperform
Nov 15, 2021 Wells Fargo INITIATE Overweight
Nov 15, 2021 Credit Suisse INITIATE Outperform
Nov 15, 2021 Piper Sandler INITIATE Overweight
Nov 15, 2021 Goldman Sachs INITIATE Buy

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
May 1, 20265840076%
Apr 1, 20265840076%
Mar 1, 20265840076%
Feb 1, 20265840076%
Jan 1, 20265840076%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

50°
Neutral
Bearish Neutral Bullish
3 mentions 0 bullish 0 bearish 2 time periods

Reddit Sentiment History

DateMentionsSentimentBullishBearishThreads
Apr 29, 2026250° Neutral002
Apr 29, 2026150° Neutral001

Recent Reddit Threads

r/wallstreetbets Neutral 22d ago
I’m nutting to $COCO
▲ 1 💬 1 ⚡ 0.5
r/wallstreetbets Neutral 22d ago
I'm nutting to $COCO
▲ 1 💬 1 ⚡ 0.5
May 14, 2026
short_volume
Short Volume: COCO — 56.6% short (0.3M / 0.6M)
Short: 331,943 | Exempt: 125 | TRF Vol: 586,818 | Short Ratio: 56.6% | Off-exchange volume (dark pool + OTC)
May 5, 2026
contract
Vita Coco to Serve as Exclusive Electrolyte Beverage Partner of INTENNSE
<p>ATLANTA, May 05, 2026 (GLOBE NEWSWIRE) -- INTENNSE™, the co-ed, team-based professional tennis league, today announced a new partnership with Vit
May 5, 2026
other
The Vita Coco Company to Participate in the Goldman Sachs Global Staples Forum
<p align="justify">NEW YORK, May 05, 2026 (GLOBE NEWSWIRE) -- The Vita Coco Company, Inc. (NASDAQ: COCO) (“Vita Coco” or “the Company”), a leading h
Apr 30, 2026
short_volume
Short Volume: COCO — 63.2% short (1.7M / 2.7M)
Short: 1,676,896 | Exempt: 1,000,300 | TRF Vol: 2,655,144 | Short Ratio: 63.2% | Off-exchange volume (dark pool + OTC)
Apr 29, 2026
earnings
The Vita Coco Company Reports Strong First Quarter 2026 Financial Results and Raises Full Year Guidance
<p align="center"><em>Net Sales were $180 million, up </em>37%<em>, driven by Vita Coco Coconut Water growth of </em>42%</p>
Apr 29, 2026
earnings_calendar
COCO Q1 2026 Earnings Scheduled — 2026-04-29
Apr 28, 2026
short_volume
Short Volume: COCO — 66.9% short (0.4M / 0.7M)
Short: 448,779 | Exempt: 144 | TRF Vol: 670,691 | Short Ratio: 66.9% | Off-exchange volume (dark pool + OTC)
Apr 22, 2026
other
The Vita Coco Company Releases 2025 Impact Report
Titled “Deeper Roots for Stronger Growth,” the report reflects the public benefit corporation’s commitment to generating positive impact alongside its
Apr 15, 2026
earnings
The Vita Coco Company to Report First Quarter 2026 Financial Results on April 29, 2026
<p align="justify">NEW YORK, April 15, 2026 (GLOBE NEWSWIRE) -- The Vita Coco Company, Inc. (NASDAQ: COCO) (“Vita Coco” or “the Company”), a leading
Apr 13, 2026
short_volume
Short Volume: COCO — 72.5% short (0.4M / 0.6M)
Short: 422,000 | Exempt: 1,740 | TRF Vol: 582,325 | Short Ratio: 72.5% | Off-exchange volume (dark pool + OTC)
Apr 8, 2026
short_volume
Short Volume: COCO — 55.7% short (0.4M / 0.7M)
Short: 365,025 | Exempt: 0 | TRF Vol: 655,296 | Short Ratio: 55.7% | Off-exchange volume (dark pool + OTC)
Apr 7, 2026
short_volume
Short Volume: COCO — 83.1% short (0.4M / 0.5M)
Short: 424,236 | Exempt: 0 | TRF Vol: 510,375 | Short Ratio: 83.1% | Off-exchange volume (dark pool + OTC)
Mar 30, 2026
short_volume
Short Volume: COCO — 60.0% short (0.3M / 0.6M)
Short: 338,986 | Exempt: 1,041 | TRF Vol: 564,717 | Short Ratio: 60.0% | Off-exchange volume (dark pool + OTC)
Mar 27, 2026
short_volume
Short Volume: COCO — 68.4% short (0.5M / 0.8M)
Short: 527,538 | Exempt: 3,625 | TRF Vol: 771,000 | Short Ratio: 68.4% | Off-exchange volume (dark pool + OTC)
Mar 26, 2026
short_volume
Short Volume: COCO — 79.3% short (0.4M / 0.5M)
Short: 411,651 | Exempt: 100 | TRF Vol: 519,003 | Short Ratio: 79.3% | Off-exchange volume (dark pool + OTC)